Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of burkholderia cenocepacia and application to nationwide epidemiological analysis

Journal of Clinical Microbiology

Volumn 53, Issue 2, 2015, Pages 398-409

  Segonds, Christine ^a,b   Thouverez, Michelle ^c   Barthe, Antoine ^a,g   Bossuet Greif, Nadège ^b,d   Tisseyre, Lenka ^b,d   Plésiat, Patrick ^c   Vergnaud, Gilles ^e,f   Chabanon, Gérard ^d,h   Pourcel, Christine ^e,f  

^a CHU PURPAN   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f CNRS   (France)

^g INSTITUTE OF HUMAN GENETICS   (France)

^h TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR GEL ELECTROPHORESIS; ALLELE; ANALYTICAL PARAMETERS; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURKHOLDERIA CENOCEPACIA; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DISCRIMINATORY POWER; EPIDEMIOLOGICAL CONCORDANCE; GENE SEQUENCE; GENETIC MARKER; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; LONGITUDINAL STABILITY; MULTILOCUS SEQUENCE TYPING; MULTILOCUS VARIABLE NUMBER OF TANDEM REPEAT ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; REPRODUCIBILITY; TRANSVERSAL STABILITY; VARIABLE NUMBER OF TANDEM REPEAT; BIOLOGY; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CLASSIFICATION; CLUSTER ANALYSIS; COMPLICATION; DNA FINGERPRINTING; EVALUATION STUDY; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PROCEDURES;

BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MULTIVORANS;

BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; CYSTIC FIBROSIS; DNA FINGERPRINTING; GENETIC VARIATION; GENOME, BACTERIAL; GENOTYPE; HUMANS; MINISATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING;

EID: 84921725917     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02473-14     Document Type: Article

References (34)

1. Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, Webb AK. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19. http://dx.doi.org/10.1016/0140-6736(93)91881-L.
2. Chen JS, Witzmann KA, Spilker T, Fink RJ, LiPuma JJ. 2001. Endemic-ity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 139:643-649. http://dx.doi.org/10.1067/mpd.2001.118430.
3. LiPuma JJ, Mortensen JE, Dasen SE, Edlind TD, Schidlow DV, Burns JL, Stull TL. 1988. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr 113:859-862. http://dx.doi.org/10.1016/S0022-3476(88)80018-0.
4. Manno G, Dalmastri C, Tabacchioni S, Vandamme P, Lorini R, Mini-cucci L, Romano L, Giannattasio A, Chiarini L, Bevivino A. 2004. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center. J Clin Microbiol 42:1491-1497. http://dx.doi.org/10.1128/JCM.42.4.1491-1497.2004.
5. Sun L, Jiang RZ, Steinbach S, Holmes A, Campanelli C, Forstner J, Tan Y, Riley M, Goldstein R. 1995. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med 1:661-666. http://dx.doi.org/10.1038/nm0795-661.
6. Mahenthiralingam E, Simpson DA, Speert DP. 1997. Identification of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 35:808-816.
7. Baldwin A, Sokol P, Parkhill J, Mahenthiralingam E. 2004. The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun 72:1537-1547. http://dx.doi.org/10.1128/IAI.72.3.1537-1547.2004.
8. Liu L, Spilker T, Coenye T, LiPuma JJ. 2003. Identification by subtrac-tive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains. J Clin Microbiol 41:2471-2476. http://dx.doi.org/10.1128/JCM.41.6.2471-2476.2003.
9. Lindstedt BA. 2005. Multiple-locus variable number tandem repeats analysis for genetic fingerprinting of pathogenic bacteria. Electrophoresis 26:2567-2582. http://dx.doi.org/10.1002/elps.200500096.
10. Vergnaud G, Pourcel C. 2006. Multiple locus VNTR (variable number of tandem repeat) analysis, p 83-104. In Stackebrandt E (ed), Molecular identification, systematics, and population structure of prokaryotes. Springer-Verlag, Berlin, Germany.
11. van Belkum A. 2007. Tracing isolates of bacterial species by multilocus variable number of tandem repeat analysis (MLVA). FEMS Immunol Med Microbiol 49:22-27. http://dx.doi.org/10.1111/j.1574-695X.2006.00173.x.
12. Grissa I, Bouchon P, Pourcel C, Vergnaud G. 2008. On-line resources for bacterial micro-evolution studies using MLVA or CRISPR typing. Biochimie 90:660-668. http://dx.doi.org/10.1016/j.biochi.2007.07.014.
13. Vergnaud G, Pourcel C. 2009. Multiple locus variable number of tandem repeats analysis. Methods Mol Biol 551:141-158. http://dx.doi.org/10.1007/978-1-60327-999-4-12.
14. Thierry S, Tourterel C, Le Flèche P, Derzelle S, Dekhil N, Mendy C, Colaneri C, Vergnaud G, Madani N. 2014. Genotyping of French Bacillus anthracis strains based on 31-loci multi locus VNTR analysis: epidemiology, marker evaluation, and update of the Internet genotype database. PLoS One 9:e95131. http://dx.doi.org/10.1371/journal.pone.0095131.
15. U'Ren JM, Hornstra H, Pearson T, Schupp JM, Leadem B, Georgia S, Sermswan RW, Keim P. 2007. Fine-scale genetic diversity among Burk-holderia pseudomallei soil isolates in Northeast Thailand. Appl Environ Microbiol 73:6678-6681. http://dx.doi.org/10.1128/AEM.00986-07.
16. Yen MWS, Lisanti O, Thibault F, San TS, Kee LG, Hilaire V, Jiali L, Neubauer H, Vergnaud G, Ramisse V. 2009. Validation of ten new polymorphic tandem repeat loci and application to the MLVA typing of Burkholderia pseudomallei isolates collected in Singapore from 1988 to 2004. J Microbiol Methods 77:297-301. http://dx.doi.org/10.1016/j.mimet.2009.03.005.
17. Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, Taylor P, Vandamme P. 2000. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38:910-913.
18. Mahenthiralingam E, Bischof J, Byrne S, Radomski C, Davies J, Av-Gay Y, Vandamme P. 2000. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burk-holderia multivorans, Burkholderia stabilis, and Burkholderia cepacia geno-movars I and III. J Clin Microbiol 38:3165-3173.
19. van Belkum A, Tassios P, Dijkshoorn L, Haeggman S, Cookson B, Fry NK, Fussing V, Green J, Feil E, Gerner-Smidt P, Brisse S, Struelens M, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Epidemiological Markers (ESGEM). 2007. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 13(Suppl 3):1-46. http://dx.doi.org/10.1111/j.1469-0691.2007.01786.x.
20. Segonds C, Bingen E, Couetdic G, Mathy S, Brahimi N, Marty N, Plesiat P, Michel-Briand Y, Chabanon G. 1997. Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol 35:2055-2060.
21. Dasen SE, LiPuma JJ, Kostman JR, Stull TL. 1994. Characterization of PCR-ribotyping for Burkholderia (Pseudomonas)cepacia. J Clin Microbiol 32:2422-2424.
22. Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MC, Govan JR, Speert DP, Lipuma JJ, Vandamme P, Dowson CG. 2005. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 43:4665-4673. http://dx.doi.org/10.1128/JCM.43.9.4665-4673.2005.
23. Jolley KA, Chan MS, Maiden MC. 2004. mlstdbNet-distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics 5:86. http://dx.doi.org/10.1186/1471-2105-5-86.
24. Dalmastri C, Baldwin A, Tabacchioni S, Bevivino A, Mahenthiralingam E, Chiarini L, Dowson C. 2007. Investigating Burkholderia cepacia complex populations recovered from Italian maize rhizosphere by multilocus sequence typing. Environ Microbiol 9:1632-1639. http://dx.doi.org/10.1111/j.1462-2920.2007.01273.x.
25. Baldwin A, Mahenthiralingam E, Drevinek P, Pope C, Waine DJ, Henry DA, Speert DP, Carter P, Vandamme P, LiPuma JJ, Dowson CG. 2008. Elucidating the global epidemiology of Burkholderia multivorans in cystic fibrosis bymultilocus sequence typing. J Clin Microbiol 46:290-295. http://dx.doi.org/10.1128/JCM.01818-07.
26. Waine DJ, Henry DA, Baldwin A, Speert DP, Honeybourne D, Mahen-thiralingam E, Dowson CG. 2006. Reliability of multilocus sequence typing of the Burkholderia cepacia complex in cystic fibrosis. J Cyst Fibros 6:215-219. http://dx.doi.org/10.1016/j.jcf.2006.10.003.
27. Drevinek P, Mahenthiralingam E. 2010. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 16:821-830. http://dx.doi.org/10.1111/j.1469-0691.2010.03237.x.
28. Campana S, Taccetti G, Ravenni N, Favari F, Cariani L, Sciacca A, Savoia D, Collura A, Fiscarelli E, De Intinis G, Busetti M, Cipolloni A, d'Aprile A, Provenzano E, Collebrusco I, Frontini P, Stassi G, Tran-cassini M, Tovagliari D, Lavitola A, Doherty CJ, Coenye T, Govan JR, Vandamme P. 2005. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy. J Clin Microbiol 43:5136-5142. http://dx.doi.org/10.1128/JCM.43.10.5136-5142.2005.
29. Mahenthiralingam E, Baldwin A, Dowson CG. 2008. Burkholderia cepa-cia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 104:1539-1551. http://dx.doi.org/10.1111/j.1365-2672.2007.03706.x.
30. Coenye T, LiPuma JJ. 2002. Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis. J Infect Dis 185:1454-1462. http://dx.doi.org/10.1086/340279.
31. Sobral D, Le Cann P, Gerard A, Jarraud S, Lebeau B, Loisy-Hamon F, Vergnaud G, Pourcel C. 2011. High-throughput typing method to identify a non-outbreak-involved Legionella pneumophila strain colonizing the entire water supply system in the town of Rennes, France. Appl Environ Microbiol 77:6899-6907. http://dx.doi.org/10.1128/AEM.05556-11.
32. Sobral D, Mariani-Kurkdjian P, Bingen E, Vu-Thien H, Hormigos K, Lebeau B, Loisy-Hamon F, Munck A, Vergnaud G, Pourcel C. 2012. A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey ofPseudomonas aeruginosain cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 31:2247-2256. http://dx.doi.org/10.1007/s10096-012-1562-5.
33. Sobral D, Schwarz S, Bergonier D, Brisabois A, Feßler A, Gilbert F, Kadlec K, Lebeau B, Loisy-Hamon F, Treilles M, Pourcel C, Vergnaud G. 2012. High throughput multiple locus variable number of tandem repeat analysis (MLVA) ofStaphylococcus aureusfrom human, animal and food sources. PLoS One 7:e33967. http://dx.doi.org/10.1371/journal.pone.0033967.
34. Scholz HC, Vergnaud G. 2013. Molecular characterisation of Brucella species. Rev Sci Tech 32:149-162.